International Journal of Cell Biology

International Journal of Cell Biology / 2019 / Article

Corrigendum | Open Access

Volume 2019 |Article ID 9050626 | https://doi.org/10.1155/2019/9050626

Syed Ahmad Tajudin T-Johari, Fatimah Hashim, Wan Iryani W. Ismail, Abdul Manaf Ali, "Corrigendum to “Combinatorial Cytotoxic Effects of Gelam Honey and 5-Fluorouracil against Human Adenocarcinoma Colon Cancer HT-29 Cells In Vitro”", International Journal of Cell Biology, vol. 2019, Article ID 9050626, 1 page, 2019. https://doi.org/10.1155/2019/9050626

Corrigendum to “Combinatorial Cytotoxic Effects of Gelam Honey and 5-Fluorouracil against Human Adenocarcinoma Colon Cancer HT-29 Cells In Vitro”

Received02 Jul 2019
Accepted04 Jul 2019
Published18 Jul 2019

In the article titled “Combinatorial Cytotoxic Effects of Gelam Honey and 5-Fluorouracil against Human Adenocarcinoma Colon Cancer HT-29 Cells In Vitro” [1], the name of the third author was given incorrectly as Wan Iryani Ismail. The author’s name should have been written as Wan Iryani W. Ismail. The revised authors’ list is shown above.

References

  1. S. A. T. T-Johari, F. Hashim, W. I. Ismail, and A. M. Ali, “Combinatorial cytotoxic effects of gelam honey and 5-fluorouracil against human adenocarcinoma colon cancer HT-29 cells in vitro,” International Journal of Cell Biology, vol. 2019, Article ID 3059687, 10 pages, 2019. View at: Publisher Site | Google Scholar

Copyright © 2019 Syed Ahmad Tajudin T-Johari et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

601 Views | 203 Downloads | 0 Citations
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.